Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Third party laboratory data management: Perspective with respect to clinical data management
Jasmin Johnson1, Vishwanath Kanagali1, D Prabu1
1Cognizant Technologies and Solutions - Life Science, Business Process Service, Kensington SEZ, Hiranandani Business Park, Powai, Mumbai, Maharashtra, India.
Managing third-party laboratory data is crucial for clinical trials. Effective vendor selection, tracking, and evaluation by data managers mitigate risks associated with outsourced analytical services.
Area of Science:
- Clinical trial management
- Data analytics
- Pharmaceutical research
Background:
- Third-party laboratories provide essential analytical services for biological samples in clinical trials.
- Outsourcing laboratory services offers advantages but introduces inherent risks to data integrity and trial management.
Purpose of the Study:
- To highlight the significance of third-party laboratory data in clinical trial data management.
- To emphasize the critical role of data managers in overseeing and mitigating risks associated with external laboratory vendors.
Main Methods:
- The study focuses on the process of selecting, tracking, and evaluating third-party laboratory vendors.
- It underscores the continuous monitoring required before, during, and after vendor contracts.
Main Results:
- Effective management of third-party vendor data is vital for successful clinical trials.
- Proactive vendor assessment by pharmaceutical companies is necessary to ensure data quality and compliance.
Conclusions:
- Data managers play a pivotal role in the successful integration and management of outsourced laboratory data.
- Robust vendor management strategies are essential to harness the benefits of outsourcing while minimizing associated risks in clinical trials.
More Related Videos
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Drug Analysis Methods
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview